Roberto Leon-Ferre
Onco
Daily
Twitter
Facebook
Youtube
RSS Feed
Linkedin
Facebook
RSS
Twitter
Youtube
Linkedin
June, 2024
June 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
« May
Roberto Leon-Ferre
Jun 21, 2024, 06:47 |
Insight
Filippo Montemurro: Not all pCR are made equal
Filippo Montemurro, Senior Medical Director at F. Hoffmann La Roche, shared a post on X: "Impact…
Jun 4, 2024, 02:39 |
Blog
Matthew Goetz: Dr. Roberto Leon Ferre receives the ASCO Conquer Cancer Advanced Clinical Research Award in Breast Cancer!
Matthew Goetz, Professor of Oncology at Mayo Clinic, shared a post on LinkedIn: "I want to…
Apr 7, 2024, 11:53 |
Insight
Roberto Leon-Ferre: The role of immune activation on the prognosis of early TNBC if chemo is not given?
Roberto Leon-Ferre, Assistant Professor at Mayo Clinic, shared on X/Twitter: "What is the role of…
Apr 5, 2024, 16:38 |
Insight
Roberto Leon-Ferre: The role of immune activation on the prognosis of early TNBC if chemotherapy is not given
Roberto Leon-Ferre, Medical Oncologist at Mayo Clinic, shared on their X/Twitter: ''What is the role…
All:
4
Posts:
1 - 10
Eliot Levitt: The Yvonne Awards demonstrate something that it doesn't hurt to be reminded of
New data from the NEST clinical trial was presented at ESMOGI24 - Agenus
Zainab Shinkafi-Bagudu's latest commentary on Cervical Cancer Elimination Forum
New Paper Alert! Amivantamab-Lazertinib Improves Outcomes in High-Risk EGFR-Mutant NSCLC Subgroups: MARIPOSA Study Results
Learn more about overcoming barriers to immunotherapy for microsatellite stable colorectal cancer
Facebook
RSS Feed
Twitter
Linkedin
Youtube